HTG Molecular Diagnostics to Host Key Opinion Leader Meeting on the Future of Precision Medicine
TUCSON, Ariz. , Dec. 03, 2019 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that it will host a Key Opinion Leader (KOL) luncheon at 12:00 pm ET on Friday, December 13 th in Boston,
- Category:
- Press Releases